Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon

Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis

NCT01491100 ·Status: COMPLETED

Physical Disability in Patients Treated With Betaferon

NCT00873340 ·Status: COMPLETED

Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis

NCT01184833 ·Status: COMPLETED

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)

NCT01706055 ·Status: COMPLETED

Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients

NCT00928967 ·Status: COMPLETED

BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program

NCT01233245 ·Status: COMPLETED

Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.

NCT01031459 ·Status: COMPLETED

Betaferon® Regulatory Post-Marketing Surveillance

NCT01414816 ·Status: COMPLETED

Rehabilitation Study in MS Patients

NCT00780455 ·Status: TERMINATED ·Phase: PHASE4

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron

NCT00461396 ·Status: COMPLETED

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

NCT00787657 ·Status: COMPLETED

Physical Activity and Fatigue in Early Multiple Sclerosis (MS)

NCT00882453 ·Status: COMPLETED

Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b

NCT03408093 ·Status: COMPLETED

Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon

NCT02486640 ·Status: COMPLETED

Phase I BP Interferon (IFN) Beta-001

NCT02515695 ·Status: COMPLETED ·Phase: PHASE1

Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis

NCT01795872 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients

NCT01201343 ·Status: COMPLETED ·Phase: PHASE4

QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in Korea

NCT01071694 ·Status: WITHDRAWN

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients

NCT00099502 ·Status: COMPLETED ·Phase: PHASE3

BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study

NCT00185211 ·Status: COMPLETED ·Phase: PHASE3

Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)

NCT00313976 ·Status: WITHDRAWN ·Phase: PHASE3

Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis

NCT00235989 ·Status: COMPLETED ·Phase: PHASE2

Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis

NCT01158183 ·Status: COMPLETED

Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis

NCT00370071 ·Status: COMPLETED ·Phase: PHASE3

The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis

NCT00917839 ·Status: UNKNOWN ·Phase: PHASE2